Redirecting to https://apnews.com/press-release/business-wire/phase-iii-find-ckd-results-show-bayers-kerendia-finerenone-improved-egfr-slope-and-reduced-risk-of-a-composite-kidney-cardiovascular-outcome-in-adults-with-non-diabetic-chronic-kidney-disease-0a13e328eb854dd0a7c3912d8766a651